CASE REPORT
A 19-year-old man with headaches and a first epileptic seizure and diagnosis of composite pleomorphic xanthoastrocytoma-ganglioglioma of the right temporal lobe
More details
Hide details
1
Department of Interventional Radiology and Neuroradiology, Medical University, Lublin, Poland
2
Students’ Scientific Society, Department of Interventional Radiology and Neuroradiology, Medical University, Lublin, Poland
3
Department of Neurology, Medical University, Lublin, Poland
Corresponding author
Eryk Mikos
Department of Interventional Radiology and Neuroradiology, Medical University of Lublin, Poland
KEYWORDS
TOPICS
ABSTRACT
Composite pleomorphic xanthoastrocytoma (PXA)–gangliocytoma (GC) is an exceptionally rare biphasic CNS tumour, often associated with epilepsy in young adults. The case report involves a 19-year-old male presenting with a first seizure and severe headaches. Neuro-imaging showed a heterogeneous, solid-cystic lesion with calcifications and vivid contrast enhancement in the right medial temporal lobe. Slight progression on follow-up MRI led to complete surgical resection. Histopathology confirmed a composite tumour with GC features (dysmorphic neurons, NeuN+, synaptophysin+, CD34+) and PXA components (pleomorphic astrocytes, GFAP+, Rosenthal fibres, eosinophilic granular bodies, foam cells, desmoplasia). Ki-67 was <1%, and p53 expression was limited to PXA. This case underscores the diagnostic challenges of mixed glioneuronal–astrocytic tumours and the importance of multimodal evaluation, including imaging, histopathology, and molecular profiling.
REFERENCES (19)
1.
Mehrotra A, Singh S, Kanjilal S, et al. Factors affecting seizure outcome in long-term epilepsy associated tumours (LEATs) in children and young adolescents. Clin Neurol Neurosurg. 2020;197:106104.
2.
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumours of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–1251.
3.
Abdel Razek AA, Elsebaie NA, Zamora C, Castillo M. Imaging of neuronal and mixed glioneuronal tumours. J Comput Assist Tomogr. 2020;44(3):356–369.
4.
Bale TA, Rosenblum MK. The 2021 WHO Classification of Tumours of the Central Nervous System: an update on pediatric low-grade gliomas and glioneuronal tumours. Brain Pathol. 2021;31(4):e12960.
5.
Wang Z, Ma J. Case report: Rare case of multinodular and vacuolar neuronal tumours in the cerebellum. Front Neurol. 2023;14:1309209.
6.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumours of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–820.
7.
Pekmezci M, Stevers M, Phillips JJ, et al. Multinodular and vacuolating neuronal tumour of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol. 2018;135(3):485–488.
8.
Krauze AV. Glioneuronal tumours: insights into a rare tumour entity. In: Haque A, ed. Gliomas: Classification, Clinical Features and Treatment Options. Exon Publications; 2021:211–218. Accessed September 1, 2025.
https://exonpublications.com/i....
9.
Slegers RJ, Blumcke I. Low-grade developmental and epilepsy associated brain tumours: a critical update 2020. Acta Neuropathol Commun. 2020;8(1):27.
10.
Huse JT, Edgar MA, Fuller GN, et al. Multinodular and vacuolating neuronal tumours: a novel epilepsy-associated lesion featuring disorganized architecture and distinctive cytology. Acta Neuropathol. 2013;125(5):657–669.
11.
Crainic N, Furtner J, Pallud J, et al. Rare neuronal, glial and glioneuronal tumours in adults. Cancers. 2023;15(4):1120.
12.
Robinson LJ, Goold E, Potter S, et al. A pleomorphic xanthoastrocytoma highlighting the morphological heterogeneity of this uncommon tumour. J Neuropathol Exp Neurol. 2024;83(1):61–64.
13.
Ebrahimi A, Korshunov A, Reifenberger G, et al. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. Acta Neuropathol Commun. 2022;10(1):5.
14.
Olejnik A, Bala A, Dziedzic T, et al. Executive dysfunction profile in mesial temporal lobe epilepsy. Acta Neuropsychol. 2024;22(1):1–13.
15.
Pachalska M, Góral-Półrola J. Focal epilepsy and executive dysfunction in Autism Spectrum Disorder (ASD). Acta Neuropsychol. 2022;20(2):211–224.
16.
Treder-Rochna N, Witkowska M. Neuropsychological consequences of COVID-19: Current approach and clinical recommendations. Acta Neuropsychol. 2024;22(1):107–128.
17.
Ren Y, Qin Z. SARS-CoV-2 spike protein interactions with glioblastoma cellular receptors: Implications for tumour progression. J Neurooncol. 2025;133(4):567–575.
18.
Farrag M, Abd Essattar Abd Elhakeem A, Algheriany A, Elshanawany A. Pleomorphic xanthoastrocytoma: Case series and review of literature. Egypt J Neurosurg. 2025;40(10).
19.
Vaz A, Cavalcanti MS, da Silva Junior EB, Ramina R, de Almeida Teixeira BC. Uncommon glioneuronal tumours: A radiologic and pathologic synopsis. AJNR Am J Neuroradiol. Published online December 15, 2022.